4//SEC Filing
Pearce Michael Cooper 4
Accession 0001354488-12-006210
CIK 0001024126other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 5:44 PM ET
Size
14.0 KB
Accession
0001354488-12-006210
Insider Transaction Report
Form 4
Pearce Michael Cooper
Director
Transactions
- Sale
Common Stock
2012-11-26$7.18/sh−25,917$186,133→ 36,667 total - Exercise/Conversion
Common Stock
2012-11-23$4.20/sh+8,800$36,960→ 45,467 total - Exercise/Conversion
Common Stock
2012-11-26$4.20/sh+25,917$108,851→ 62,584 total - Exercise/Conversion
Employee Stock Option (right to buy)
2012-11-26−25,917→ 9,583 totalExercise: $4.20Exp: 2013-03-09→ Common Stock (25,917 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2012-11-23−8,800→ 35,500 totalExercise: $4.20Exp: 2013-03-09→ Common Stock (8,800 underlying) - Sale
Common Stock
2012-11-23$7.41/sh−8,800$65,234→ 36,667 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/16/2012.
- [F2]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.32 to $7.48, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option which represents a right to purchase a total of 137,500 shares of which 93,200 were purchased prior to 11/23/2012 became fully exercisable on 3/9/2010.
- [F4]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.45, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
PERNIX THERAPEUTICS HOLDINGS, INC.
CIK 0001024126
Entity typeother
Related Parties
1- filerCIK 0001413616
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 5:44 PM ET
- Size
- 14.0 KB